In addition to the three major pathogenic genes and APOE ε4, genome-wide association studies (GWAS) have revealed a large number of AD susceptibility loci, while whole genome sequencing (WGS) and whole exome sequencing (WES) studies have identified many AD-associated rare variants. This evidence concerns the gene APOE and Alzheimer disease.